Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: J07BB02

Fluad Tetra(A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) / A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022 IVR-237) / B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) / B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, BVR-1B) influenza virus)

Influenza, Human

Marketing Authorisation Holder: Seqirus Netherlands B.V.

EMA Authorisation: 20/05/2020

INN: influenza vaccine (surface antigen, inactivated, adjuvanted)

Indication

Prophylaxis of influenza in adults 50 years of age and older. Fluad Tetra should be used in accordance with official recommendations.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Fluad Tetra — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Fluad TetraCreate Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.